Akari Therapeutics (AKTX) Other financing activities (2015 - 2025)
Akari Therapeutics' (AKTX) quarterly Other financing activities came in at $33000.0 in Q2 2025, up 375.0% year-on-year from $6947.4 in Q2 2024, and up 266.67% quarter-over-quarter from $9000.0 in Q4 2024.
Akari Therapeutics (AKTX) Other financing activities (2015 - 2025) Analysis & Trends
Akari Therapeutics has disclosed Other financing activities across 3 years of filings, most recently posting $33000.0 for Q2 2025.
- Other financing activities for Q2 2025 came in at $33000.0, up 375.0% year-over-year; the trailing twelve-month figure through Jun 2025 was $223000.0 (up 14072.43% YoY), and the FY2024 annual result was $193000.0, changed N/A from the prior year.
- Other financing activities came in at $33000.0 for Q2 2025 at Akari Therapeutics, up from $9000.0 in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $193000.0 in Q3 2024 to a low of -$12000.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 33,000.00 |
| Jun 30, 2025 | 33,000.00 |
| Dec 31, 2024 | 9,000.00 |
| Dec 31, 2024 | 9,000.00 |
| Sep 30, 2024 | 193,000.00 |
| Sep 30, 2024 | 193,000.00 |
| Jun 30, 2024 | -12,000.00 |
| Jun 30, 2024 | -12,000.00 |
| Mar 31, 2024 | 3,000.00 |
| Mar 31, 2024 | 3,000.00 |
| Dec 31, 2015 | 7,404.00 |
| Dec 31, 2015 | 7,404.00 |